Literature DB >> 23105801

Usefulness of ferroxidase activity of ceruloplasmin in the diagnosis of Wilson's disease.

J J Fleming1, S Santhosh, R Selvakumar, A Jose, C E Eapen.   

Abstract

Serum ceruloplasmin is one of the most commonly used screening tests for Wilson's disease. However immunological assays for ceruloplasmin are not recommended for diagnosis and management of Wilson's disease through calculation of free copper index. Enzymatic methods using non-physiological substrates have toxicity and stability problems, making them difficult to automate. Ferroxidase assays may be a satisfactory alternative for measuring serum ceruloplasmin. The o-dianisidine hydrochloride manual method for estimation of serum ceruloplasmin enzyme activity was compared with an automated method using the ferroxidase activity of ceruloplasmin in measurement in a double blind study in 91 consecutive patients screened for Wilson's disease. The o-dianisidine and ferroxidase methods both successfully identified 7 patients with Wilson's disease. Values for these 7 patients in the o-dianisidine and ferroxidase methods were median 5.0 (range 0-16.0 U/L) and median 45.0 (range 4-166 U/L) respectively. There were 7 other positive values (<62 U/L) with the o-diansidine method and 2 (<200 U/L) with the ferroxidase method, where WD was not confirmed. ROC curves for both methods showed area under the curve of 0.998 for o-dianisidine and 0.997 for ferroxidase. Using literature cut off values of 62 U/L and 200 U/L respectively both methods had 100% sensitivity and specificity was 91.7% (o-dianisidine) and 97.6% (ferroxidase). For the o-dianisidine assay, specificity was improved to 98.8% using a cut off of 22.5 U/L. In the 84 persons (46 adults and 38 children) in whom the diagnosis of Wilson's disease was not established, the mean value for ceruloplasmin activity by the o-dianisidine and ferroxidase methods was 124.7 ± 48.7 U/L and 571.4 ± 168.1 U/L respectively. There were no significant differences between sex or age of patients (p > 0.29). In a subsequent evaluation with 372 specimens, the Pearson correlation coefficient between the assays was 0.908, p < 0.01, slope 4.06, intercept 265.8, with the manual assay as the x-axis. The ferroxidase assay is a suitable replacement for the o-dianisidine assay in detecting patients with Wilson's disease.

Entities:  

Keywords:  Ceruloplasmin; Ferroxidase; Wilson’s Disease; o-dianisidine

Year:  2009        PMID: 23105801      PMCID: PMC3453472          DOI: 10.1007/s12291-009-0003-4

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  9 in total

1.  Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice.

Authors:  Patrick J Twomey; Adie Viljoen; Ivan M House; Timothy M Reynolds; Anthony S Wierzbicki
Journal:  Clin Chem       Date:  2005-08       Impact factor: 8.327

2.  A kinetic method for determination of serum ceruloplasmin.

Authors:  H Mukerjee
Journal:  Clin Chem       Date:  1990-02       Impact factor: 8.327

3.  Standardization of serum ceruloplasmin concentrations in international enzyme units with o-dianisidine dihydrochloride as substrate.

Authors:  H P Lehmann; K H Schosinsky; M F Beeler
Journal:  Clin Chem       Date:  1974-12       Impact factor: 8.327

4.  Iron accumulation in the liver of male patients with Wilson's disease.

Authors:  Y Shiono; S Wakusawa; H Hayashi; T Takikawa; M Yano; T Okada; H Mabuchi; S Kono; H Miyajima
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

5.  Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride.

Authors:  K H Schosinsky; H P Lehmann; M F Beeler
Journal:  Clin Chem       Date:  1974-12       Impact factor: 8.327

6.  The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum.

Authors:  S Osaki; D A Johnson; E Frieden
Journal:  J Biol Chem       Date:  1966-06-25       Impact factor: 5.157

Review 7.  Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.

Authors:  J M Walshe
Journal:  Ann Clin Biochem       Date:  2003-03       Impact factor: 2.057

Review 8.  Wilson's Disease.

Authors:  Peter Ferenci
Journal:  Clin Gastroenterol Hepatol       Date:  2005-08       Impact factor: 11.382

9.  Automated measurement of serum ferroxidase activity.

Authors:  O Erel
Journal:  Clin Chem       Date:  1998-11       Impact factor: 8.327

  9 in total
  1 in total

Review 1.  Genetics of Wilson's disease: a clinical perspective.

Authors:  S Suresh Kumar; George Kurian; C E Eapen; Eve A Roberts
Journal:  Indian J Gastroenterol       Date:  2012-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.